Showing results (521-530 of 1,063) with videos related to

Sort By:
Pageof 107
Alzheimer'S & Dementia (New York, N. Y.)|August 20, 2026
Engaging Hispanic/Latino young adults in Alzheimer's disease research through boot camp translationMichelle N Martinez, Stacey Moeller, Mirna Arroyo-Miranda, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 28, 2025
Impact of study partner replacement in a mild cognitive impairment clinical trialLucy A Dolmadjian, Mary Ryan Baumann, Joshua D Grill, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 21, 2024
A service-oriented approach to clinical trial recruitment for dementia and brain health: Methods and case examples of MyAlliance for Brain HealthEric D Vidoni, Emma Swinford, Kelli Barton, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 7, 2026
Physical inactivity in preclinical Alzheimer's disease: Risk factor, early symptom, or both?Jiawei Zhao, Xin Li, Mengxuan Wu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 7, 2026
Thalamic volume alterations mediate glymphatic function and cognitive dysfunction in Alzheimer's diseaseLeian Chen, Xiao Zhou, Bin Zhang, et al.
Alzheimer'S & Dementia (New York, N. Y.)|May 23, 2025
Association of allostatic load with all-cause and cause-specific dementia: A prospective cohort studyYifan Gou, Xin Qi, Chen Liu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 22, 2026
Dementia progression with GLP-1 receptor agonists in people with mild cognitive impairment and type 2 diabetes: target-trial emulation studyMeir Schechter, Dvora R Sehtman-Shachar, Alisa Fishkin, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 16, 2026
Effects of long-term daily supplementation with vitamin D3 and marine omega-3 fatty acids on change in ADRD biomarkers: A secondary analysis of a randomized clinical trialChirag M Vyas, Beth L Ostaszewski, Amirah K Anderson, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 25, 2026
Humanized APP is the primary determinant of regional brain volume in humanized APOE knock-in mice: a cross-sectional ex vivo MRI studyAvnish Bhattrai, Adam C Raikes, Roberta Diaz Brinton
Alzheimer'S & Dementia (New York, N. Y.)|October 18, 2022
The Alzheimer's Cell Atlas (TACA): A single-cell molecular map for translational therapeutics accelerator in Alzheimer's diseaseYadi Zhou, Jielin Xu, Yuan Hou, et al.
Pageof 107